Account
22.01.2026 2:00 PM - 3:00 PM GMT
Event Host
Paul Craddy
Event Description

2026 is already shaping up to be a pivotal year for market access, are you ready for the pressure points and new pathways ahead?

Join Remap Consulting for a live 60-minute briefing on the top trends that will shape access, pricing, and launch planning in 2026. From shifting launch geographies to tighter evidence standards and a surge in patient voice, this session will break down the must-watch themes — and what they really mean for manufacturers.

Here’s what we’ll explore:

  • US Price Pressure Goes Global: MFN & IRA impact on launch sequencing and pricing corridors
  • New Geographies, New First-Wave Strategies: Why the Middle East is pulling ahead
  • JCA Reality Check: How the EU’s joint assessment is playing out in practice
  • The Rise of Private Access: When public budgets tighten, patients go elsewhere
  • The Patient Voice Gets Louder: PED and value frameworks in flux

Whether you’re in market access, pricing, HEOR, or strategic planning, this is your chance to benchmark your 2026 readiness against what’s coming fast.

 

Why You Should Attend

  • Understand how global price reform is rewriting access assumptions
  • Learn how HTA and launch planning are evolving across US, EU & growth markets
  • Get clarity on payer behaviours and hidden strategic levers for 2026
  • Ask your questions live in our interactive Q&A
Register Here

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.